Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02651428 · ClinicalTrials.gov registry record · Phase 3
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
A Phase 3 study, sponsored by CorMedix.
- Completed
- Registry status
- Phase 3
- Development phase
- 806
- Enrollment target
NCT02651428 is a Phase 3 study that has completed, run by CorMedix. The registered enrollment target is 806 participants.
The verdict
NCT02651428, a Phase 3 study, has completed, sponsored by CorMedix.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 806 participants
- Enrollment target
Study Summary
The purpose of this study is determine safety and effectiveness of Neutrolin, a catheter lock solution, for prevention of central venous catheter associated bloodstream infection in hemodialysis patients.
Interventions
- DRUG Heparin
- DRUG Neutrolin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02651428
The ClinicalTrials.gov registry entry for NCT02651428 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 806 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CorMedix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Heparin is the first listed.
NCT02651428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02651428 about?
NCT02651428 is a clinical study titled "Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection". The purpose of this study is determine safety and effectiveness of Neutrolin, a catheter lock solution, for prevention of central venous catheter associated bloodstream infection in hemodialysis patients.
What is the current status of trial NCT02651428?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 806 participants. The study started on 2015-12. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02651428?
The interventions under investigation include: Heparin (DRUG), Neutrolin (DRUG).
Who is sponsoring clinical trial NCT02651428?
This trial is sponsored by CorMedix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.